IL-12, a heterodimeric protein consisting of the p35 and p40 subunits, is a pleiotropic proinflammatory cytokine with potent tumor-suppressive activity that represents a promising candidate for combinatorial immunotherapy [6–8, 14]. Here, IL12A is linked to neoplasm.